MARCHI, SANTINO
 Distribuzione geografica
Continente #
NA - Nord America 27.529
AS - Asia 13.788
EU - Europa 10.811
SA - Sud America 1.674
Continente sconosciuto - Info sul continente non disponibili 564
AF - Africa 435
OC - Oceania 59
Totale 54.860
Nazione #
US - Stati Uniti d'America 26.612
CN - Cina 4.214
SG - Singapore 4.119
IT - Italia 3.850
HK - Hong Kong 2.111
SE - Svezia 1.494
BR - Brasile 1.367
VN - Vietnam 1.054
DE - Germania 892
BG - Bulgaria 871
KR - Corea 770
CA - Canada 695
UA - Ucraina 687
GB - Regno Unito 660
FI - Finlandia 565
FR - Francia 510
TR - Turchia 469
RU - Federazione Russa 433
CH - Svizzera 303
IN - India 244
JP - Giappone 239
CI - Costa d'Avorio 142
AT - Austria 140
BD - Bangladesh 127
AR - Argentina 85
NL - Olanda 77
MX - Messico 74
BE - Belgio 64
IQ - Iraq 63
PL - Polonia 57
ES - Italia 49
AU - Australia 48
EC - Ecuador 45
NG - Nigeria 45
SN - Senegal 43
CO - Colombia 42
ZA - Sudafrica 42
SA - Arabia Saudita 41
ID - Indonesia 39
VE - Venezuela 37
PK - Pakistan 35
CL - Cile 34
CR - Costa Rica 34
JM - Giamaica 34
MA - Marocco 32
UZ - Uzbekistan 32
EG - Egitto 25
PY - Paraguay 25
MY - Malesia 24
PH - Filippine 23
JO - Giordania 21
CZ - Repubblica Ceca 20
IL - Israele 20
NP - Nepal 20
TN - Tunisia 20
KE - Kenya 19
DZ - Algeria 18
BJ - Benin 16
IR - Iran 15
LT - Lituania 15
NO - Norvegia 15
PE - Perù 15
TT - Trinidad e Tobago 15
AZ - Azerbaigian 14
PT - Portogallo 14
UY - Uruguay 14
HU - Ungheria 13
IE - Irlanda 13
LB - Libano 13
AE - Emirati Arabi Uniti 12
GR - Grecia 12
NI - Nicaragua 12
TH - Thailandia 12
GT - Guatemala 11
NZ - Nuova Zelanda 11
HN - Honduras 10
RS - Serbia 9
DK - Danimarca 8
ET - Etiopia 8
EU - Europa 8
PA - Panama 8
SK - Slovacchia (Repubblica Slovacca) 8
TW - Taiwan 8
BO - Bolivia 7
OM - Oman 7
AL - Albania 6
BN - Brunei Darussalam 5
DO - Repubblica Dominicana 5
KZ - Kazakistan 5
RO - Romania 5
SI - Slovenia 5
BB - Barbados 4
BH - Bahrain 4
HR - Croazia 4
KH - Cambogia 4
PS - Palestinian Territory 4
AO - Angola 3
GA - Gabon 3
GE - Georgia 3
KG - Kirghizistan 3
Totale 54.241
Città #
Ashburn 2.564
Woodbridge 2.320
Singapore 2.254
Ann Arbor 2.131
Hong Kong 2.076
Houston 1.688
Chandler 1.508
San Jose 1.402
Fairfield 1.381
Serra 1.185
Santa Clara 1.017
Dallas 989
Jacksonville 921
Milan 919
Hefei 912
Sofia 867
Seoul 749
Beijing 728
Shanghai 680
New York 628
Seattle 617
Council Bluffs 599
Wilmington 536
Cambridge 519
Ottawa 518
Boardman 420
Princeton 382
Lawrence 346
Nanjing 335
Lauterbourg 320
Medford 319
Los Angeles 305
Bern 293
Des Moines 271
Izmir 245
Tokyo 222
Ho Chi Minh City 220
Helsinki 200
Dearborn 193
London 191
Buffalo 173
Istanbul 173
Jüchen 168
Hanoi 164
Dong Ket 154
Abidjan 142
Nanchang 134
Vienna 117
Redondo Beach 113
Boulder 111
Florence 103
São Paulo 103
Munich 97
San Diego 97
Redwood City 96
Kunming 84
Pisa 81
Orem 79
Frankfurt am Main 75
Rome 75
Changsha 62
Hebei 58
Tianjin 58
Brussels 57
Shenyang 57
Washington 57
Toronto 51
Chicago 50
Atlanta 47
Phoenix 46
Lagos 45
Montreal 44
Columbus 43
Ogden 43
Chennai 42
Dakar 42
Amsterdam 40
Rio de Janeiro 40
San Francisco 40
Verona 34
Warsaw 34
Bremen 33
Jiaxing 33
Norwalk 33
Falls Church 32
Haiphong 32
Brasília 31
Brooklyn 31
Guangzhou 31
Nuremberg 31
Da Nang 30
Paris 30
Pune 30
Tashkent 30
The Dalles 30
Düsseldorf 29
Belo Horizonte 28
Orange 28
San José 28
Turku 28
Totale 37.877
Nome #
Evaluation of Pancreatic Exocrine Function in Patients With Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas 573
Voluntary and controlled weight loss can reduce symptoms and proton pump inhibitor use and dosage in patients with gastroesophageal reflux disease: A comparative study 508
Serum gamma-glutamyltransferase fractions in myotonic dystrophy type I: differences with healthy subjects and patients with liver disease 301
Irritable bowel syndrome: a disease still searching for pathogenesis, diagnosis and therapy 283
Management of Chronic constipation in general practice 275
Differential diagnosis between functional and organic intestinal disorders: is there a role for non-invasive tests? 273
Vegetal and Animal Food Proteins Have a Different Impact in the First Postprandial Hour of Impedance-pH Analysis in Patients with Heartburn 270
Symptom analysis improves GERD diagnosis and may be helpful to define a successful surgical approach 268
Gastroesophageal reflux symptoms among Italian university students: Epidemiology and dietary correlates using automatically recorded transactions 259
Gastric mucosal distribution and clinical efficacy of azithromycin in patients with Helicobacter pylori related gastritis 256
Neuroendocrine Dysregulation in Irritable Bowel Syndrome Patients: A Pilot Study 243
Lactobacillus Casei DG® in Patients with Irritable Bowel Syndrome: Not Only a Change of the Gut Microbiota. A Pilot Study 239
Eosinophilic esophagitis: clinical, endoscopic, histologic and therapeutic differences and similarities between children and adults 237
Parallel increase of circulating CXCL11 and CXCL10 in mixed cryoglobulinemia, while the proinflammatory cytokine IL-6 is associated with high serum Th2 chemokine CCL2. 236
Symptom patterns can distinguish diverticular disease from irritable bowel syndrome. 235
Assessment of serum cytokines predicts clinical and endoscopic outcomes to vedolizumab in ulcerative colitis patients 235
Randomised clinical trial: twice daily esomeprazole 40 mg vs. pantoprazole 40 mg in Barrett’s oesophagus for 1 year 230
Pros and Cons of the SeHCAT Test in Bile Acid Diarrhea: A More Appropriate Use of an Old Nuclear Medicine Technique 225
Helicobacter pylori eradication: a randomized prospective study of triple therapy versus triple therapy plus lactoferrin and probiotics 221
Abdominal ultrasound scan for the follow-up of pancreatic cystic lesions: could it play a role as a safe and cost-saving alternative to the routine MRI? 218
Not all anti-reflux treatment failures are due to persistence of abnormal esophageal acid exposure 216
Overlap of functional heartburn and gastroesophageal reflux disease with irritable bowel syndrome 216
Esophageal chemical clearance and baseline impedance values in patients with chronic autoimmune atrophic gastritis and gastro-esophageal reflux disease 214
Rabeprazole is equivalent to omeprazole in the treatment of erosive gastro-oesophageal reflux disease. A randomised, double-blind, comparative study of rabeprazole and omeprazole 20 mg in acute treatment of reflux oesophagitis, followed by a maintenance open-label, low-dose therapy with rabeprazole 214
Platelet serotonin transporter in patients with diarrhea-predominant irritable bowel syndrome both before and after treatment with alosetron 209
Influence of the serotonin transporter 5HTTLPR polymorphism on symptom severity in irritable bowel syndrome 209
Dynamics of persistent TT virus infection, as estimated in patients treated with alpha interferon for concomitant hepatitis C 208
Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liver disease 208
Famotidine in the short-term treatment of duodenal ulcer and of concomitant peptic lesions : comparison with cimetidina 205
Thrombocytopenic purpura: an unusual complication of eradication therapy for Helicobacter pylori 203
Can interferon-ribavirin effectively treat patients who did not respond to a first conventional therapy by interferon? 202
Dynamic MRI of the small bowel: usefulness of quantitative contrast-enhancement parameters and time-signal intensity curves for differentiating between active and inactive Crohn's disease. 201
Low FODMAP diet: Evidence, doubts, and hopes 201
Serum triiodothyronine-to-thyroxine (T3/T4) ratio predicts therapeutic outcome to biological therapies in elderly IBD patients 201
Role of faecal calprotectin as non-invasive marker of intestinal inflammation 200
How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related? 200
Clinical features of symptomatic uncomplicated diverticular disease: a multicenter Italian survey. 199
Association between baseline impedance values and response proton pump inhibitors in patients with heartburn 199
STUDIO DEGLI ACIDI BILIARI IN PAZIENTI CON COLESTASI E DRENAGGIO BILIARE PERCUTANEO ED IN PAZIENTI CON EPATOPATIA CRONICA NON COLESTATICA 198
Trauma quality indicators: internationally approved core factors for trauma management quality evaluation 198
Irritable bowel syndrome and chronic constipation: Fact and fiction 196
The general practitioner's approach to irritable bowel syndrome: from intention to practice 195
Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they? 195
Beta-lipoprotein- and LDL-associated serum Gamma-glutamiyltransferase in patients with coronary atherosclerosis 193
Gastroesophageal reflux disease, functional dyspepsia and irritable bowel syndrome: Common overlapping gastrointestinal disorders 193
Serum triiodothyronine-to-thyroxine (T3/T4) ratio predicts therapeutic outcome to biological therapies in elderly IBD patients 193
Can interferon-ribavirin effectively treat patients who did not respond to a first conventional therapy by interferon? 192
CAGA STATUS DOES NOT INFLUENCE THE ERADICATION RATE OF HELICOBACTER PYLORI INFECTION BY A ONE WEEK TRIPLE THERAPY 192
Management of chronic constipation in general practice. 192
Genetics and pharmacogenetics of aminergic transmitter pathways in functional gastrointestinal disorders 191
Clinical epidemiology of chronic viral hepatitis B: A Tuscany real-word large-scale cohort study 190
Hepatitis C virus chronic infection as a common cause of mixed cryoglobulinaemia and autoimmune liver disease 189
Bile reflux in patients with nerd is associated with more severe heartburn and lower values of mean nocturnal baseline impedance and chemical clearance 189
Oral sucrosomial iron is as effective as intravenous ferric carboxy‐maltose in treating anemia in patients with ulcerative colitis 189
Role of HCV infection in immune response to hepatitis B vaccination in chronic renal failure patients on hemodialysis. 188
CT colonography: Project of High National Interest No. 2005062137 of the Italian Ministry of Education, University and Research (MIUR) RID A-2343-2011 188
EUS-FNA wet technique for the pre-operative diagnosis of 31 solid pancreatic tumors: Pisa experience 188
Serum oncostatin M at baseline predicts mucosal healing in Crohn's disease patients treated with infliximab 187
Could double-dose PPI therapy modify tissutal homeostasis in patients with barrett esophagus? 186
Intestinal pseudo-obstruction in inactive systemic lupus erythematosus: An unusual finding 186
A seven day regimen with ranitidine bismuth citrate plus amoxycillin and clarithromycin is effective in eradicating H.Pylori and healing duodenal ulcer. 185
Patients with lactose intolerance absorb liquid levothyroxine better than tablet levothyroxine 185
Alfa-fetoproteina e dimero-D nell'epatocarcinoma e nelle epatopatie croniche 183
Manually calculated oesophageal bolus clearance time increases in parallel with reflux severity at impedance-pH monitoring 183
Presbifagia Esofagea 183
Refractory Gastroesophageal Reflux Disease: A Management Update 183
Giant cell arteritis of the leg in a patient with hepatitis C virus infection 182
Subthreshold psychiatric psychopathology in Functional gastrointestinal disorders: Can it be the bridge between gastroenterology and psychiatry? 182
Radionuclide evaluation of the lower gastrointestinal tract 181
Liver triglyceride accumulation after chronic ethanol administration: a possible protective role of metadoxina and ubiquinon 180
Consideration concerning the psyco-medical-social approach to alcohol-related problems. 180
Suspected laryngopharyngeal reflux evaluated with multichannel impedance and Ph-monitoring. How many are gerd patients? 180
Esophagogastric junction morphology is associated with a positive impedance-pH monitoring in patients with GERD 180
Extra-esophageal presentation of gastroesophageal reflux disease: New understanding in a new era 180
Barrett's esophagus in 2016: From pathophysiology to treatment 179
Double-blind, randomized trial of IFN±colchicine in anti HCV-positive chronic active Hepatitis (CAH). 178
Barrett's esophagus results of a multicentric survey 178
The pharmacokinetics of ilaprazole for gastro-esophageal reflux treatment 178
Lower pH values of weakly acidic refluxes as determinants of heartburn perception in gastroesophageal reflux disease patients with normal esophageal acid exposure 178
Esophageal motility abnormalities in gastroesophageal reflux disease 177
“PancPro” as a tool for selecting families eligible for pancreatic cancer screening: An Italian study of incident cases 176
Alcohol and women: a study in high schools 175
Alginate controls heartburn in patients with erosive and nonerosive reflux disease 174
Alcune considerazioni sull'approccio psico-medico-sociale ai problemi alcol-correlati XI Congresso S.I.A. 173
Nuclear translocation of GSTO is a progression marker in Barrett’s esophagus. 173
Genetic heterogeity of hepatitis C virus: quasispecies analysis in liver, peripheral blood mononuclear cells and plasma. 172
Vonoprazan fumarate for the management of acid-related diseases 172
Chronic active hepatitis (CAH) due to hepatitis C virus (HCV): a double-blind, randomized trial of IFN ± colchicine. 171
Esophageal testing: What we have so far 171
DUODENO-PANCREATECTOMY WITHOUT VASCULAR RESECTION FOR ISHIKAWA TYPE B ADENOCARCINOMA: UNDERTREATMENT OR NOT? 170
EUS-FNA WET-TECHNIQUE IN 31 SOLID PANCREATIC LESIONS: PISA EXPERIENCE 170
Role of abdominal ultrasound for the surveillance follow-up of pancreatic cystic neoplasms: A cost-effective safe alternative to the routine use of magnetic resonance imaging 170
Thyroid involvement in hepatitis C - Associated mixed cryoglobulinemia 170
Can computer improve the accuracy of ultrasonographic gastric emptying assessment? 169
CagA status does not influence the eradication rate of Helicobacter pylori infection by a one-week triple therapy. 169
Long-term endoscopic surveillance of patients with Barrett’s esophagus. Incidence of dysplasia and adenocarcinoma: a prospective study 169
Chronic constipation diagnosis and treatment evaluation: The "CHRO.CO.DI.T.E." study 169
Ranitidine Bismuth citrate in co-prescription with clarithromycin 1 g/day or 1.5 g/day are equally effective in the eradication of H.pylori and healing of duodenal ulcer 168
The daily diary and the questionnaire are not equivalent for the evaluation of bowel habits 168
Assessment of bowel wall inflammation in Crohn's disease by a new quantitative ultrasound analysis as compared to vascularization in healthy volunteers bowel wall. 168
Totale 20.530
Categoria #
all - tutte 152.303
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 152.303


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.191 0 0 58 254 647 477 73 181 167 82 141 1.111
2022/20234.209 508 513 270 372 540 619 43 339 652 19 275 59
2023/20243.692 601 437 616 254 469 650 79 78 63 42 83 320
2024/202510.148 53 414 140 580 711 843 771 639 1.156 1.430 1.375 2.036
2025/202611.568 799 1.825 1.317 783 1.017 1.144 1.788 571 732 1.035 307 250
2026/20273.159 851 876 1.432 0 0 0 0 0 0 0 0 0
Totale 54.860